Pharmaron Beijing Co Ltd
SZSE:300759

Watchlist Manager
Pharmaron Beijing Co Ltd Logo
Pharmaron Beijing Co Ltd
SZSE:300759
Watchlist
Price: 30.58 CNY -2.64%
Market Cap: 45.4B CNY
Have any thoughts about
Pharmaron Beijing Co Ltd?
Write Note

Pharmaron Beijing Co Ltd
Total Equity

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
|

Pharmaron Beijing Co Ltd
Total Equity Peer Comparison

Comparables:
603259
2269
300347
M
688114
W
2268

Competitive Total Equity Analysis
Latest Figures & CAGR of Competitors

Company Total Equity CAGR 3Y CAGR 5Y CAGR 10Y
Pharmaron Beijing Co Ltd
SZSE:300759
Total Equity
ÂĄ13B
CAGR 3-Years
12%
CAGR 5-Years
36%
CAGR 10-Years
N/A
WuXi AppTec Co Ltd
SSE:603259
Total Equity
ÂĄ54.7B
CAGR 3-Years
14%
CAGR 5-Years
25%
CAGR 10-Years
N/A
WuXi Biologics (Cayman) Inc
HKEX:2269
Total Equity
ÂĄ40.7B
CAGR 3-Years
7%
CAGR 5-Years
37%
CAGR 10-Years
N/A
Hangzhou Tigermed Consulting Co Ltd
SZSE:300347
Total Equity
ÂĄ20.8B
CAGR 3-Years
7%
CAGR 5-Years
41%
CAGR 10-Years
39%
M
MGI Tech Co Ltd
SSE:688114
Total Equity
ÂĄ8.6B
CAGR 3-Years
35%
CAGR 5-Years
N/A
CAGR 10-Years
N/A
W
WuXi XDC Cayman Inc
HKEX:2268
Total Equity
ÂĄ5.5B
CAGR 3-Years
144%
CAGR 5-Years
N/A
CAGR 10-Years
N/A

See Also

What is Pharmaron Beijing Co Ltd's Total Equity?
Total Equity
13B CNY

Based on the financial report for Jun 30, 2024, Pharmaron Beijing Co Ltd's Total Equity amounts to 13B CNY.

What is Pharmaron Beijing Co Ltd's Total Equity growth rate?
Total Equity CAGR 5Y
36%

Over the last year, the Total Equity growth was 13%. The average annual Total Equity growth rates for Pharmaron Beijing Co Ltd have been 12% over the past three years , 36% over the past five years .

Back to Top